chrisvoncsefalvay/vaers-outcomes huggingface dataset:
reaction to Pfizer vaccine 39 y.o. female who presents with adverse reaction to receiving the COVID vaccine. Patient described urticaria around her mouth, forehead, and anterior neck.  She received IM epinephrine from staff at vaccination center (Occupational Health).  She described significant improvement in her hives and urticaria.  She denies ever having experienced any difficulty breathing or swallowing.  She is otherwise in her usual state of health. Patient was discharged home with a prescription for diphenhydramine (25mg oral) and EPINEPHrine 0.3 mg/0.3 mL injection auto-injector. Possible link to vaccine could not be ruled out but the absence of systemic reaction is re-assuring. Tryptase was 5.4 ug/l (within normal limits). Other Labs are unremarkable. Pt was discharged home after observing for at least 2 hrs and she was advised to follow up with occupational health.
This spontaneous report as received from a nurse refers to multiple unspecified patients of unknown age and genders. On unknown dates, the patients were vaccinated with improperly stored ROTATEQ (lot # L046319, expiry date: 28-SEP-2017) orally. The vaccine was stored at a temperature of 32 F for 15 minutes and at 31 F for 15 minutes. There was no previous temperature excursion. Digital data logger was involved. No symptoms were reported. The outcome of the events was unknown. This is one of the three reports received from the same reporter. Additional information has been requested.
Moderna rec'd 2/28 and had sharp pain in right temple that wasnt consistent, and this lasted for a couple hours. Throughout the day I could still feel it but it finally subsided and I've not felt it any more.  I also developed a rash that started the same evening  because I felt this heat in my torso area and then I had a rash all over torso.
Patient notices blood in urine as Hematuria.; Fever of 100.9; Body aches; Injection site pain; This spontaneous case was reported by a patient and describes the occurrence of HAEMATURIA (Patient notices blood in urine as Hematuria.), PYREXIA (Fever of 100.9), MYALGIA (Body aches) and INJECTION SITE PAIN (Injection site pain) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011F21A) for COVID-19 vaccination.     Concurrent medical conditions included Kidney stones, Hypercalciuria and Carcinoma (was addressed 20 years ago by surgery).    On 16-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In November 2021, the patient experienced PYREXIA (Fever of 100.9), MYALGIA (Body aches) and INJECTION SITE PAIN (Injection site pain). On 19-Nov-2021, the patient experienced HAEMATURIA (Patient notices blood in urine as Hematuria.). At the time of the report, HAEMATURIA (Patient notices blood in urine as Hematuria.), PYREXIA (Fever of 100.9), MYALGIA (Body aches) and INJECTION SITE PAIN (Injection site pain) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 100.9 (High) fever of 100.9.         No concomitant medication were reported. No treatment information was reported. HCP visited and several tests were conducted however cause was not detected. Caller reported his preexisting conditions: previous kidney stones, hypercalciuria and carcinoma which was addressed 20 years ago by surgery. No allergy was reported.
I developed shingles on my face. I saw Dr on 4/19/21. I'm taking valVCYclovir 1000 mg  3 times daily for 7days.  The symptoms started with a stinging on my face. Then my right eye and right ear ache. A sore developed near my nose and since have several there and one below my right eye  the pain, stinging and earache continue
Call received from client's aunt on July 11, 2007.  States client received immunizations at our facility early in the afternoon of July 9, 2007.  Following receipt of the vaccines, client was "warm and achy" the evening of July 9.  Client felt warm to touch and aunt estimated temperature to be around 100.6 or 100.7 degrees, but temperature was not taken.  On Tuesday, July 10, 2007, client's temperature was 102 degrees by thermometer, and he was having chills and shivers along with feeling achy and having pounding in the temple area.  Client was taking Tylenol or Advil every 4 hours, which was bringing temperature down.  Today, Wednesday, July 11, 2007, client has no further fever, is cool to touch, is no longer taking fever reducing product.  Continues to feel tired and is resting on the couch. Child presented to health department without record of immunizations and is unable to obtain record from childhood.
HYPERtension & Tachycardia Narrative: Tachycardia at 160 within 5" of injection with mild hypertension from 128/90 to 167/95 for 2-3"; resolution to HR of 110 and BP 139/80 within 5". Transferred to ED for further monitoring in stable condition, awake, alert and cooperative, mentation intact.
9 days after vaccination, patient reports gradual onset of lightheadedness that started 2 days after vaccination and increased 2 days ago. His symptoms are not vertiginous and has not had syncope, and has not felt close to passing out. The symptoms are worse when he gets up and there is no lightheadedness when he is laying down. He reports that symptoms worsen throughout the day with associated symptoms including frontal headache with standing up but do not include nausea, fever, or palpitations. Patient later started experiencing SOB on exertion on 5/4/21. On 6/4/21, patient admitted to ED after noticing platelet count had decreased from 153,000 on 5/30/2021 to 14,000 on 6/3/2021. No abnormal bleeding was found and platelet factor 4 antibody was ordered to rule out vaccine-induced thrombocytopenia and thrombosis, although there have been no reports of this condition with mRNA vaccine. Incidentally on literature review, there are reports of platelet sequestration and microangiopathic hemolysis inside a vascular malformation associated with Klippel-Trenaunay syndrome.   Vitals: 4/29/21: 146/81, Pulse 66 -> 5/4/21: 145/82, Pulse 96, 14 -> 6/6/2021: 142/79, 54, 16  Labs 6/5/2021-6/6/2021:  WBC 4.50 - 11.00 K/uL 4.04 (L)  RBC 4.5 - 5.9 M/uL 4.37 (L)  Hgb 13.5 - 17.5 g/dL 12.7 (L)  Hematocrit 41 - 53 % 39.0 (L)  Platelet Count 150 - 450 K/uL 19 (LL)  Neutrophils 40.00 - 70.00 % 34.1 (L)  Immature Granulocytes 0.0 - 0.5 % 1.0 (H)  Lymphocytes 22 - 44 % 54.7 (H)  Absolute Neutrophils 1.80 - 7.70 K/uL 1.38 (L)  Absolute Immature Granulocytes 0.00 - 0.03 K/uL 0.04 (H) PF4 IgG: negative    Dizziness slowly improved and pt underwent EKG, BMP, CBC, thyroid screen, CT head, CT chest that did not reveal cause of symptoms. Other symptoms also starting to improve prior to hospitalization for thrombocytopenia. Subsequent provider visits focused on Klippel-Trenaunay syndrome and idiopathic thrombocytopenic purpura.  "
patient experienced a rash that was like that of Shingles; This non-serious case was reported by a physician via sales rep and described the occurrence of vesicular rash in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced vesicular rash (Verbatim: patient experienced a rash that was like that of Shingles). The outcome of the vesicular rash was not reported.   It was unknown if the reporter considered the vesicular rash to be related to Shingrix.     It was unknown if the company considered the vesicular rash to be related to Shingrix.   Additional Information: GSK receipt date: 19-May-2023 The patient had experienced a rash that was like that of Shingles following a dose of Shingrix. The reporter did not consent to follow-up.
Hot arm; Arm still red; Arm still swollen; This case was reported by a consumer via interactive digital media and described the occurrence of extremities hot feeling of in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On 9th February 2022, the patient received Shingrix. In February 2022, less than a week after receiving Shingrix, the patient experienced extremities hot feeling of, erythema of extremities and swelling arm. On an unknown date, the outcome of the extremities hot feeling of, erythema of extremities and swelling arm were not recovered/not resolved.   It was unknown if the reporter considered the extremities hot feeling of, erythema of extremities and swelling arm to be related to Shingrix.  Additional details were provided as follows: The patient self-reported this report. The age at vaccination was not reported. The patient had the vaccine for shingles on Wednesday and his/her arm was still hot, red and swollen. The patient asked that how long this should last. The follow-up could not be possible as no contact details were available
Increase in circulation issues, fingers turning purple.; having longer period duration/Increase in menstrual flow; Increase is Asthma attacks; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  An 18-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 20Feb2021 at 09:45 as dose 1, single (Lot number: EW0181) at the age of 18 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Chronic Migraines" (unspecified if ongoing); "Asthma" (unspecified if ongoing); "Allergies: Latex" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: PERIPHERAL CIRCULATORY FAILURE (medically significant) with onset 01Mar2021, outcome "recovered with sequelae", described as "Increase in circulation issues, fingers turning purple."; ASTHMA (medically significant) with onset 01Mar2021, outcome "recovered with sequelae", described as "Increase is Asthma attacks"; HEAVY MENSTRUAL BLEEDING (medically significant) with onset 01Mar2021, outcome "recovered with sequelae", described as "having longer period duration/Increase in menstrual flow". The events "increase in circulation issues, fingers turning purple.", "having longer period duration/increase in menstrual flow" and "increase is asthma attacks" required physician office visit and emergency room visit. The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Negative. Therapeutic measures were taken as a result of peripheral circulatory failure, heavy menstrual bleeding, asthma.  Clinical course: On 01Aug2021 patient was administered with dose 2 on left arm location. Patient took treatment was received for AE with Inhaler/Nebulizer/Dehumidifier. Increase in circulation issues fingers turning purple. Increase is asthma attacks. Also, she has been experiencing Increase in menstrual flow and having longer period Duration. Example I had a period for 5 straight weeks.  Follow-up attempts are completed. No further information is expected.
Pt has a history of asthma. Pt states after she recieved the vaccine she started coughing. Pt states she used her albuterol inhaler. Pt states she also took 50MG of benadryl. Pt states her symptoms are gone at this time. Pt's vitals are stable. Pt refused transport to hospital.
Pt seen by MD on 8/26/01 with onset 4 days post vaccination of itchy, erythematous papules 1-2 cm with appearance of insect bites but not known hx of exposure. Approxiamtely 10 lesions over body on left arm, back thigh, abdomen and ankle. Pt was seen first for condition at urgent care and started on Prednisone.
Two days after receiving the second dose I experienced numbness and weakness in my right hand, especially the pinky finger. The numbness has improved, but the weakness and decreased range of motion hasn't improved.
cough; runny nose; fuzzy headed/scatter brained; not sleeping good; This is a spontaneous report from a contactable consumer (patient). A 41-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; lot: WEN5318), via an unspecified route of administration on left arm on 28Jan2021 (at the age of 41years) at single dose for covid-19 immunization. Medical history included scratchy throat the day before the vaccine (27Jan2021). The patient had no concomitant medications and no investigation assessment. The patient got first dose of vaccine 28Jan2021 and was debating whether to get Covid test because of symptoms. The patient had a cough and runny nose on 29Jan2021 and fuzzy headed, scatter brained and not sleeping good in 2021. The patient considered the events as non-serious. Asked if these symptoms were from the vaccine and if getting the vaccine cause a false positive on the Covid test. Stated Friday had cough and runny nose. He stated that it felt like he had a pretty bad head cold and would not think about getting tested but since Covid was around. Wanted to know if these were common side effects of the vaccine or if he needed to get tested. The patient just moved houses and it was a stressful process. Sometimes when one gets stressed that one gets sick and may have contributed to his condition. Later clarified that this was for the Pfizer Covid 19 vaccine. The patient stated that the cough and runny nose worsened over the weekend and was a little better now and took alpha lipoic acid;minerals nos;quercetrin;vitamins nos (EMERGEN-C). The outcome of the events cough and rhinorrhea was recovering while unknown for the remaining events.
Information has been received from a consumer concerning her 12 month old son who on 08-APR-2009 was vaccinated with MMR II. Concomitant therapy included amoxicillin and DTaP. On 12-APR-2009 4 days after administration of the vaccine the patient developed low grade fever. On 13-APR-2009 the fifth day the patient experienced a febrile seizure and was examined in the emergency room. The patient was not admitted and was currently being treated with MOTRIN and TYLENOL. The patient received other vaccines the day he received MMR II but it was unknown which vaccines. The patient still had a fever intermittently. At the time of reporting the patient's febrile seizure persisted. Follow-up information has been received from the physician that the patient had the flu and ear infection about 1 week prior to receiving the MMR II vaccination. The physician stated that the patient had a well check-up visit with the physician on 08-APR-2009 and at that visit the patient received the MMR II vaccination along with other concomitant vaccinations (not reported). Two days (previously reported as 5 days after vaccination) after receiving the vaccinations the patient had a febrile seizure and was seen at hospital and not admitted. The physician also reported that she prescribed a stronger antibiotic for the patient at that time. The physician said that it was too early to tell if the patient had recovered. The patient had scheduled appointment for later in the month of April. Follow-up information has been received from a Licensed Practical Nurse that the patient received the MMR II (lot # 661675/1505X) on 08-APR-2009. The patient did not receive any concomitant vaccines on 08-APR-2009. It was reported that the patient received PEDIARIX on 08-OCT-2008. It was reported that after the patient had a febrile seizure he was taken to another hospital (not at the hospital as previous reported). Follow-up information has been received from the physician that the patient with otitis media (OM) and no allergy at the time of vaccination was vaccinated with his first dose of MMR II (lot # 661675/1505X) SQ into his left thigh on 09:27 AM 08-APR-2009. The patient was vaccinated with his first dose of VARIVAX (Merck) (lot # 660669/1381X) SQ into his right thigh on 09:27 08-APR-2009. The patient was vaccinated with his first dose of HAVRIX (lot # 1297X) IM into his right thigh on 09:26 08-APR-2009. The patient was vaccinated with his fourth dose of PREVNAR (lot # D34347) IM into his left thigh on 09:28 08-APR-2009. The patient had febrile seizure and was seen in emergency room. No diagnostic and laboratory test was done. At the time of reporting, the patient had recovered from febrile seizure. Upon internal review, febrile seizure was considered to be an other important medical event. No further information is available.
Memory loss, difficulty concentrating, fatigue on the day of the vaccine. Next day, complained of dry throat and chills and diaphoresis. Out of work for 2 days and then c/o diarrhea. Stated came back to work and then was out again for 3 days with the same symptoms. Also c/o phlegm.
Pain in the shoulder, Loss of mobility in the shoulder, started within 48 hours of injection.
Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Feb-2021 at 3:21 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 13-Feb-2021 at 3:21 PM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). In 2021, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Age of patient was reported as 66.75 for dose administered on 13-FEB-2021 . No concomitant medications were reported. Batch number 031L20A underwent temperature excursion on 13-FEB-2021 with temperature 32 degrees Fahrenheit from 09:00 AM. This vial was moved to fridge on 09-FEB-2021 and beyond use date for the vial was reported as 10-MAR-2021. Product moved to clinic on 13-JAN-2021. Vial was in cooler storage and was not in frozen storage during high-pace COVID-19 vaccination at around 2021. Vials were only punctured right before administration. Vaccines were not frozen at time of administration. It was reported that each time a vial was put into a cooler, sometimes there was a period of 1 hour or 1 hour and a half approximately, when temperature data logger registered a temperature of 34- or 35-degree Fahrenheit. Temperature recordings were taken using a  traceable temperature monitor at every hour. No treatment medications were reported.   This case was linked to MOD-2022-566976 (Patient Link).
ITCHING, SWELLING 2IN X 2IN X 1/4IN, WITH HEAT
Within a few minutes of injection, patient reported feeling hot and dizzy. Had known hx of anxiety with previous Covid vaccine injection and interpreter states "she was anxious like this last time too". Patient lower to the floor and remained in sitting position per her request. 1:28-BP-170/88, T-97.8, O2 sat-99% Fruit snacks and water given. Reassurance provided. 1:42-BP-136/86, P-80, O2sat-99%. Via interpreter reports feeling much better. 1:49-left accompanied by interpreter and other coworker.
Approx 4 hours after vaccine the patient reported sweats, dizziness, and inability to focus. VS were stable. Patient was taken to ED and worked up. She received Benedryl, Solumedrol and IV fluids.
Headache; Little bit of fever; On and off chills; Felt very fatigue; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache), PYREXIA (Little bit of fever), CHILLS (On and off chills) and FATIGUE (Felt very fatigue) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In February 2021, the patient experienced HEADACHE (Headache), PYREXIA (Little bit of fever), CHILLS (On and off chills) and FATIGUE (Felt very fatigue). At the time of the report, HEADACHE (Headache), PYREXIA (Little bit of fever), CHILLS (On and off chills) and FATIGUE (Felt very fatigue) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications or treatment details provided.
pt recvd vax & esp allerg react p/dose #3; itching & hives occurred 30 mins p/dose 3; flushing & redness occurred the next morning; allerg react was treated w/DPH
Arms, Knee, ankles and feet soles swollen, severe pain when making force and patient refers not being able to lift objects or perform any type of work that requires some type of force.
"This is a 60y.o. female with a PMH of pneumonia, partial lung resection, asthma, GERD, Hepatitis C, and bladder mass presented to EC with c/o worsening shortness of breath over past week associated with cough, fever, diarrhea, headache, body aches and loss of taste & smell."; admitted on 09/15/21.
Patient was calm, sitting in waiting room with his mother when he suddenly began vomiting, roughly 10 minutes after administration of the MMR vaccine. He had several episodes of forceful, nonbloody nonbilious emesis that resolved on its own. He had no difficulty breathing, no rash, and no other symptoms following his emesis.
As per caller she received her 1st dose on 27Dec2020 and they did a test for her on 14Jan2021 the test for covid came back positive on 17Jan2021; Had first vaccine dose then had rapid and PCR test done and tested positive; This is a spontaneous report received from a contactable nurse (patient). A 48-years-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: Unknown), via an unspecified route of administration on 27Dec2020 as single dose (48 years at the time of vaccination) for covid-19 immunization. The patient's medical history and concomitant medications were not reported. Follow-ups (26Feb2021) were received from same reporter and were processed together with initial information. On 14Jan2021, the patient had a rapid Covid-19 test and results came back positive on 17Jan2021. However, she was expected to get the second dose on the 17Jan2021, but she did not. Then on 19Jan2021, she had PCR test and was tested positive. She was told not to Pfizer doctor because of testing positive for COVID. She would like to know if she needs to start over or if she can take, make appointment for her second dose because she is getting conflicting information, her cardiologist says that she needs to wait 90 days and then she talked to pharmacist that said no, she doesn't need to, she can "fed up" (not clarified) her appointment and she would just like to know what she should do. In Feb2021 she was tested positive for Covid-19 again, and she was tested for Covid-19 again yesterday, but she doesn't have her results yet. The outcome of events was unknown.